Figure 1From: Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case reportHistological and immunohistochemical findings in the primary tumor: (A) adenocarcinoma with mixed papillary and acinar subtype (hematoxylin and eosin 40× magnification), (B) Immunohistochemical analysis of the ALK protein expression in the tumor cells, (C) Fluorescence in situ hybridization (FISH) analysis of EML4-ALK. Back to article page